Distinct changes in brain metabolism in patients with dementia and hearing loss

Brain Behav. 2024 Jan;14(1):e3374. doi: 10.1002/brb3.3374.

Abstract

Introduction: Previous studies have reported that hearing loss (HL) is associated with dementia, although the mechanistic underpinnings remain elusive. This study aimed to evaluate the changes in brain metabolism in patients with HL and different types of dementia.

Methods: Patients with cognitive impairment (CI) and HL treated at the university-based memory clinic from May 2016 to October 2021 were included. In total, 108 patients with CI and HL prospectively underwent audiometry, neuropsychological test, magnetic resonance imaging, and 18 F-fluorodeoxyglucose positron emission tomography. Twenty-seven individuals without cognitive impairment and hearing loss were enrolled as a control group. Multivariable regression was performed to evaluate brain regions correlated with each pathology type after adjusting for confounding factors.

Results: Multivariable regression analyses revealed that Alzheimer's disease-related CI (ADCI) was associated with hypometabolic changes in the right superior temporal gyrus (STG), right middle temporal gyrus (MTG), and bilateral medial temporal lobe. Lewy body disease-related CI (LBDCI) and vascular CI were associated with hypermetabolic and hypometabolic changes in the ascending auditory pathway, respectively. In the pure ADCI group, the degree of HL was positively associated with abnormal increase of brain metabolism in the right MTG, whereas it was negatively associated with decreased brain metabolism in the right STG in the pure LBDCI group.

Conclusion: Each dementia type is associated with distinct changes in brain metabolism in patients with HL.

Keywords: FDG-PET; brain metabolism; cognitive impairment; dementia; hearing loss.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alzheimer Disease* / pathology
  • Brain / pathology
  • Cognitive Dysfunction* / pathology
  • Dizocilpine Maleate / analogs & derivatives*
  • Fluorodeoxyglucose F18 / metabolism
  • Hearing Loss* / complications
  • Hearing Loss* / metabolism
  • Hearing Loss* / pathology
  • Humans
  • Positron-Emission Tomography

Substances

  • 5-aminocarbonyl-10,11-dihydro-5H-dibenzo(a,d)cyclohepten-5,10-imine
  • Fluorodeoxyglucose F18
  • Dizocilpine Maleate